Pubblicazioni

  • Home
  • Pubblicazioni
 
Alemtuzumab-related lymphocytes subset dynamics and disease activity or autoimmune adverse event
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Assessing treatment response in pediatric multiple sclerosis patients
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Autologous hematopoietic stem cell transplantation reduces disability progression in patients with secondary progressive multiple sclerosis: results from the Italian MS Register
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Comparative effectiveness of early intensive or escalation treatment strategies on long term disability trajectories in relapsing multiple sclerosis patients
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Exit-strategies in Natalizumab-treated RRMS at high risk of progressive multifocal leukoencephalopathy: A multicentre comparison study
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Exit-strategy in Natalizumab responders RRMS patients: an Italian comparison among Ocrelizumab, Rituximab and Cladribine
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Italian multicenter observational study on real-life experience with alemtuzumab in naive patients with aggressive multiple sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Long term disability progression in early and late onset pediatric multiple sclerosis patients
Giacomo Lus
Giacomo Lus
Vai all’articolo »
 
Long-term disability progression in childhood and adolescent onset multiple sclerosis patients
Giacomo Lus
Giacomo Lus
Vai all’articolo »